Seizure relief for participant in clinical trial (IMAGE)
Caption
Annette Adkins, walking in her Portland neighborhood, has been nearly seizure-free since undergoing an experimental procedure at OHSU on Oct. 26 implanting inhibitory nerve cells into a precisely defined focal point in the brain to quell seizures. Known as NRTX-1001 neuronal cell therapy, the technique has been tried in two patients nationwide so far as part of an ongoing multisite clinical trial.
Credit
Christine Torres Hicks/Oregon Health & Science University
Usage Restrictions
OHSU offers select multimedia assets for use by news outlets. (Commercial use is prohibited without prior written consent.) When using this image, please: Credit photo with “OHSU/Christine Torres Hicks.” Photographer name, caption and usage restrictions are embedded in the image metadata. Do not alter the content/nature of the photo. Color correction and cropping are allowed. Image should be credited to OHSU. For more information, please contact OHSU Strategic Communications at news@ohsu.edu or 503-494-8231.
License
Original content